Artificial Urinary Sphincter Implantation Device Market

An artificial urinary sphincter (AUS) is an implanted device to treat urinary incontinence in men. The AUS is designed to supplement the function of the natural urinary sphincter that restricts urine flow out of the bladder.
Artificial Urinary Sphincter Implantation Device Market contains market size and forecasts of Artificial Urinary Sphincter Implantation Device in global, including the following market information:
Global Artificial Urinary Sphincter Implantation Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Artificial Urinary Sphincter Implantation Device Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Artificial Urinary Sphincter Implantation Device companies in 2021 (%)
The global Artificial Urinary Sphincter Implantation Device market was valued at 17 million in 2021 and is projected to reach US$ 18 million by 2028, at a CAGR of 0.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
AMS 800 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Urinary Sphincter Implantation Device include Boston Scientific, ZEPHYR Surgical Implants, RBM-Med, Silimed and GT Urological, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Artificial Urinary Sphincter Implantation Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Urinary Sphincter Implantation Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Artificial Urinary Sphincter Implantation Device Market Segment Percentages, by Type, 2021 (%)
AMS 800
Other
Global Artificial Urinary Sphincter Implantation Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Artificial Urinary Sphincter Implantation Device Market Segment Percentages, by Application, 2021 (%)
Men
Women
Global Artificial Urinary Sphincter Implantation Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Artificial Urinary Sphincter Implantation Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Urinary Sphincter Implantation Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Artificial Urinary Sphincter Implantation Device revenues share in global market, 2021 (%)
Key companies Artificial Urinary Sphincter Implantation Device sales in global market, 2017-2022 (Estimated), (Units)
Key companies Artificial Urinary Sphincter Implantation Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific
ZEPHYR Surgical Implants
RBM-Med
Silimed
GT Urological